Methanesulfonic acid methyl 2-imino-3-methyl-2,3-dihydro-1,3-benzothiazole-6-carboxylate
CAS: 2034455-56-4
Ref. 3D-JGD45556
| 1g | Descontinuado | ||
| 50mg | Descontinuado | ||
| 100mg | Descontinuado | ||
| 250mg | Descontinuado | ||
| 500mg | Descontinuado |
Informação sobre produto
Nome:
Methanesulfonic acid methyl 2-imino-3-methyl-2,3-dihydro-1,3-benzothiazole-6-carboxylate
Descrição:
Methanesulfonic acid methyl 2-imino-3-methyl-2,3-dihydro-1,3-benzothiazole-6-carboxylate (MSI) is a derivative of imatinib and has been used in the treatment of cancer. MSI is a reactive compound that can form hydrogen bonds with other compounds. It has been shown to have an acidic pH of 1.0 in water vapor. MSI also has an absorption maximum at 280 nm due to the presence of a trifluoromethanesulfonic acid group. MSI crystallizes into different polymorphs depending on the conditions under which it is purified, including amorphous and crystalline solids. The particle size distribution for these polymorphs ranges from 0.1 to 5 microns, with an average particle size of 1 micron.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
318.4 g/mol
Fórmula:
C11H14N2O5S2
Pureza:
Min. 95%
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
